Publications by authors named "Boming Zuo"

Claim this Profile
I
Isovalerylspiramycin I Reprograms the Immunosuppressive and Temozolomide-Resistant Microenvironment by Inhibiting the Frizzled-5/Wnt/β-Catenin Pathway in Glioblastoma.
Xin Luo, Xiangyang Zhong, Tianci Zeng, Xiaodie Li, Tao Yang, Boming Zuo

Research (Wash D C)· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Framework nucleic acid-based nanoparticles enhance temozolomide sensitivity in glioblastoma.
Yufei Lan, Xiaodie Li, Boyang Liu, Jiankun Lu, Boming Zuo, Huaqin Zuo

Drug Resist Updat· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Histone H3K9 Lactylation Confers Temozolomide Resistance in Glioblastoma via LUC7L2-Mediated MLH1 Intron Retention.
Qu Yue, Zhao Wang, Yixiong Shen, Yufei Lan, Xiangyang Zhong, Boming Zuo

Adv Sci (Weinh)· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IRP1 mediated ferroptosis reverses temozolomide resistance in glioblastoma via affecting LCN2/FPN1 signaling axis depended on NFKB2.
Yufei Lan, Tao Yang, Qu Yue, Zhao Wang, Xiangyang Zhong, Boming Zuo

iScience· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis